Forte Health Advisors

What Forte Health Advisors does

Forte Health Advisors (legal name: Forte Advisors) is a Boston-based, privately-held healthcare advisory boutique founded in 2016 by three former senior executives: Terri Bresenham (former GE Corporate Officer and CEO of GE Healthcare India), Hooman Hakami (former Medtronic Executive Committee EVP, previously President of GE's $2B X-Ray business), and Pete Tarsney (former GE Healthcare executive, corporate lawyer, and SEC investigator). The firm provides long-term, capital-efficient strategic advisory services to healthcare companies from seed stage through Series C or IPO, and to venture capital and private equity firms for transaction diligence and thesis development. Its core offering is structured as a multi-year partnership in which one partner typically sits on the client's board as an independent director while all three partners contribute on high-priority issues, supported by direct capital investment in select companies and access to a global healthcare network spanning Africa, India, South Asia, Southeast Asia, Europe, and North America.

Services are organized by company stage. Early-stage engagements cover capital sourcing, corporate governance, IP strategy, global regulatory strategy, technology prototyping, and design for manufacturability. Launch-stage engagements cover market sizing, pricing, reimbursement, value-based care strategy, talent identification, and adoption barriers. Growth-stage engagements (Series A through IPO) cover gross margin optimization, M&A process, IPO readiness and execution, public-company compliance, investor relations, manufacturing at scale, global distribution, and capital planning. Forte is not a technology company and has no proprietary software, AI/ML products, or API; the firm's product is the partner-level expertise, board representation, and network access delivered through direct B2B advisory engagements.

The business model combines three revenue streams: annual advisory retainer fees (subscription-style, scaled to company stage), equity participation in select portfolio companies, and direct capital investment in select companies alongside network-based capital sourcing. Go-to-market is purely direct — partners engage CEOs, founders, and boards of healthcare companies through referrals and personal networks, supplemented by a corporate website and individual LinkedIn profiles. Disclosed clients include startups such as Qure.ai, Mpirik, PathMaker Neurosystems, Quanta, Pristine Surgical, Rhino Health, Tata MD, ASTR, GCX, and NOMO, alongside enterprise and PE relationships with Carlyle, Audax, Indegene, and Linden. The firm has no disclosed external funding, no parent company, and no subsidiaries.

Name

Forte Health Advisors

Legal name

Forte Advisors

Website

https://forteadv.com

Company type

Private

Founded year

2016

Operating status

Operating

Headcount range

1–10 employees

Short description

Forte Health Advisors is a Boston-based three-partner boutique providing long-term strategic advisory, board representation, and capital sourcing to healthcare companies from seed stage through IPO, plus diligence support to healthcare-focused VC and PE firms.

Ownership category

akta.pro rank

Product category

Healthcare Strategic Advisory

NAICS

Management Consulting Services (54161), Management, Scientific, and Technical Consulting Services (5416)

SIC

Services-Management Consulting Services (8742)

akta.pro primary industry

Strategy & Corporate Development Consulting (BPAHACAA)

akta.pro secondary industries

M&A Advisory (Buy-Side & Sell-Side) (BPAHAOAA), Corporate Development & Strategic Partnerships Advisory (JVs, Alliances, Carve-outs) (BPAHAOAG), M&A Advisory (Buy-side/Sell-side) (BPAHADAC), Corporate Strategy Advisory (BPAHADAA)

Keywords

• Healthcare strategic advisory
• Executive advisory services
• Board advisory consulting
• Growth stage advisory
• Investor diligence services

Headquarters

HQ city

Boston

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

1. Advisory Retainer Fees: Annual retainer fees for advisory services, structured similar to board member compensation. Fee structure is stage-dependent and scaled to a company's needs within their particular stage of growth.
2. Equity Compensation: Equity participation in select companies as part of aligned incentive structure, providing long-term upside alignment with company success.
3. Capital Investment: Direct capital investment in select companies to propel advancement to key milestones, in addition to leveraging network for capital sourcing.

Pricing tiers

Go-to-market motion2 records

Distribution channels1 record

Marketing channels2 records

Core offering

Forte Health Advisors provides long-term, capital-efficient strategic advisory engagements to innovative healthcare companies from seed stage through Series C or IPO. Three founding partners deliver board-level guidance across company formation, regulatory strategy, market introduction, commercialization, scaling, and exit preparation, and additionally serve healthcare-focused venture capital and private equity firms with thesis development, transaction diligence, and board placement.

Product overview

Forte Health Advisors is a healthcare advisory services firm that provides strategic consulting and expertise to healthcare companies across various growth stages. The company offers a comprehensive suite of advisory services organized by growth phase: Early Stage services (Capital Sourcing, Corporate Governance, IP Strategy & Licensing, Global Regulatory Strategy, Technology Prototyping, Design for Manufacturability); Launch Stage services (Market Sizing and Prioritization, Pricing Strategy, Reimbursement, Value-Based Care Strategies, Talent Identification, Overcoming Adoption Barriers); and Monetization Stage services (Gross Margin Optimization, Acquisition Process, IPO Readiness + Execution, Public Company Compliance, Investor Relations, Manufacturing at Scale, Global Footprint/Distribution, Capital Planning, Cash Flow Optimization, HR Systems and Structures, Multi-generational Planning). Forte is not a product company but rather a partnership of experienced healthcare executives who provide long-term, capital-efficient advisory engagements, typically serving as board members and offering access to their global network of healthcare leaders.

Differentiator

Problem solved

Functional benefit

Products and services

• Early-Stage Healthcare Advisory Multi-year strategic advisory engagement for seed-stage healthcare companies covering capital sourcing, corporate governance, IP strategy and licensing, global regulatory strategy, technology prototyping, and design for manufacturability. Designed for founders and early boards establishing company foundations.
• Launch-Stage Healthcare Advisory Strategic advisory engagement for healthcare companies introducing products to market, covering market sizing and prioritization, pricing strategy, reimbursement, value-based care strategies, talent identification, and overcoming adoption barriers.
• Growth-Stage Healthcare Advisory (Monetization Stage) Strategic advisory engagement for Series A through IPO-stage healthcare companies covering gross margin optimization, acquisition process, IPO readiness and execution, public company compliance, investor relations, manufacturing at scale, global footprint and distribution, capital planning, cash flow optimization, HR systems, and multi-generational planning.
• Healthcare Investor Advisory (VC/PE) Strategic advisory services for healthcare-focused VC and PE firms covering thesis development, pressure testing, game-board development, target identification, confirmatory diligence, and board placement. Engages with investment firms directly to support portfolio construction and transaction evaluation.

Quantifiable outcome

• Helped grow Medtronic Diabetes Group from $1.8B to approximately $2.5B
• +3 more outcomes

Named customers14 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Six partnerships are on record, tiered core and minor.

• MpirikcoreStrategic or Co-development PartnerHooman Hakami serves on the board of Mpirik, a SaaS company using AI and big data to identify high-risk Cardiovascular patients who need specialized care or surgery. This represents a strategic relationship where Forte expertise directly supports portfolio company growth.
• PathMaker NeurosystemscoreStrategic or Co-development PartnerHooman Hakami serves on the board of PathMaker Neurosystems, the only multi-site non-invasive neuromodulation company focused on treatment of neurological disease. Forte provides board-level strategic guidance.
• QuantacoreStrategic or Co-development PartnerHooman Hakami serves on the board of Quanta, a UK company providing state-of-the-art point-of-care hemodialysis solution. Forte provides strategic oversight and network access.
• five.eight Health Tech IncubatorminorStrategic or Co-development PartnerTerri Bresenham developed a health tech incubator (five.eight) during her tenure at GE to partner with regional innovation in India and Southeast Asia.
• GenWorksminorStrategic or Co-development PartnerCreated during Terri Bresenham's tenure as CEO of GE Healthcare India - a first-in-market distribution and services company to bring innovative medical technologies to semi-urban and rural markets of India.
• GE and Microsoft Healthcare Technology Joint VentureminorStrategic or Co-development PartnerPete Tarsney led the negotiation and formation of a multi-million dollar healthcare technology joint venture between GE and Microsoft during his tenure at GE Healthcare.

Scale indicators3 records

Recent moves6 records

Expansion highlights4 records

Broad incumbents

• Boston Consulting Group (Healthcare Practice): Global management consulting firm with one of the largest healthcare practices, providing strategy and operations consulting across payers, providers, medtech, and biopharma. Represents the premium incumbent competitor for enterprise-level healthcare mandates.
• Charles River Associates (Healthcare): Global consulting firm with a healthcare and life sciences practice providing strategy, economics, and litigation support to pharma, medtech, and biotech clients. Larger-scale alternative with overlapping service lines.
• McKinsey & Company (Healthcare Practice): Global management consulting firm with a dedicated healthcare systems and services practice as well as pharma/medtech products. Competes for the largest healthcare strategy mandates and influences board-level decision-making Forte targets.
• ZS Associates: Large global consulting firm with deep healthcare and life sciences practice, serving pharma, medtech, and health services clients on commercial strategy, sales, and analytics. Represents the scaled incumbent alternative to Forte's boutique offering.

Direct peers

• Triangle Insights Group: Healthcare-exclusive strategy consulting firm supporting biopharma and medical device companies with commercial strategy and asset diligence. Comparable boutique structure and focus on growth-stage healthcare clients.
• Putnam Associates: Strategy consulting firm dedicated to biopharma and medical devices, providing commercial strategy, pricing, and market access advice to growth-stage and large-cap healthcare companies. Highly comparable service mix and client profile to Forte's Growth-Stage segment.
• Trinity Partners: Healthcare strategy consulting firm focused on biopharmaceutical and medical device clients, providing strategic advisory, portfolio planning, and commercial assessments. Closely comparable boutique structure and vertical focus.
• Alira Health: Healthcare-focused advisory and consulting firm supporting medtech, biotech, and digital health companies with strategy, transaction, and product development services. Comparable boutique positioning serving growth-stage healthcare clients.
• ClearView Healthcare Partners: Healthcare-focused strategy consulting firm serving pharma, medtech, and diagnostics clients with commercial strategy, corporate development, and transaction support. Comparable boutique scale, vertical focus, and engagement style to Forte.
• Health Advances: Boston-based boutique strategy consulting firm exclusively focused on healthcare and life sciences. Closest direct peer: comparable size, similar vertical-only positioning, and similar mix of strategy, commercial, and transaction advisory for medtech, diagnostics, and digital health clients across stages.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/forte-health-advisors

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Forte Health Advisors